Characterization of cis-regulatory elements of the vascular endothelial growth inhibitor gene promoter
- 7 June 2005
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 388 (3), 913-920
- https://doi.org/10.1042/bj20041739
Abstract
VEGI (vascular endothelial growth inhibitor), a member of the tumour necrosis factor superfamily, has been reported to inhibit endothelial cell proliferation, angiogenesis and tumour growth. We identified and cloned approx. 2.2 kb of the VEGI promoter from mouse cerebral endothelial cells. The promoter contained an atypical TATA-box-binding protein sequence TAAAAAA residing at −32/−26 relative to the transcription initiation site (+1), 83 bp upstream from the ATG start codon. To investigate critical sequences in the VEGI promoter, a series of deleted and truncated segments were constructed from a 2300 bp promoter construct (−2201/+96) linked to a luciferase reporter gene. Transient transfection of cerebral microvascular cells (bEND.3) and rat C6 glioma cells demonstrated that a 1700 bp deletion from the −2201 to −501 did not significantly affect promoter activity; however, a truncated construct (−501/+96) lacking the region between −312 and −57 resulted in nearly 90% loss of promoter activity. A consensus NF-κB (nuclear factor κB) and several SP1 (specificity protein-1)-binding sequences were identified within the deleted segment. Supershift analysis revealed that NF-κB subunits, p50 and p65, interacted with the VEGI promoter. Exposure of cerebral endothermic cells to the pro-inflammatory cytokine, tumour necrosis factor-α, increased VEGI mRNA levels and DNA-binding activities, whereas an NF-κB inhibitor attenuated this increase. In addition, p65 overexpression enhanced, whereas p50 overexpression decreased, the luciferase activity. Furthermore, mutation of the NF-κB DNA binding site blocked this p65- and tumour necrosis factor-α-induced luciferase activity. These findings suggest that the transcription factor NF-κB plays an important role in the regulation of VEGI expression.This publication has 48 references indexed in Scilit:
- Dual functional roles of Tie-2/angiopoietin in TNF-α-mediated angiogenesisAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Stimulation of IRF-7 Gene Expression by Tumor Necrosis Factor αPublished by Elsevier BV ,2002
- Zinc is required in pyrrolidine dithiocarbamate inhibition of NF‐κB activationFEBS Letters, 1999
- TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMSAnnual Review of Immunology, 1999
- TL1, a Novel Tumor Necrosis Factor-like Cytokine, Induces Apoptosis in Endothelial Cells: INVOLVEMENT OF ACTIVATION OF STRESS PROTEIN KINASES (STRESS-ACTIVATED PROTEIN KINASE AND p38 MITOGEN-ACTIVATED PROTEIN KINASE) AND CASPASE-3-LIKE PROTEASEPublished by Elsevier BV ,1999
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Regulation of Cytokine-Induced iNOS Expression by a Hairpin Oligonucleotide in Murine Cerebral Endothelial CellsBiochemical and Biophysical Research Communications, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- KBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells.The Journal of Experimental Medicine, 1993